http://www.nightingalemd.ca/news-events/press-releases/ newsen-us Mon, 01 Jan 1900 12:00:00 AMTue, 17 Jan 2012 11:52:42 AM http://www.nightingalemd.ca/news-events/press-releases/?i=3354The Company hires Mr. Luc Sirois to further strengthen its presence in Quebec and accelerate its penetration of  the consumer eHealth market   Markham, ON, January 17, 2012 – Nightingale Informatix Corporation  (TSX-V: NGH) “Nightingale” or “Company”, an application service provider (ASP) of electronic medical record (EMR) software and related services today announced the appointment of Luc Sirois to the role of Vice President and General Manager for Quebec, effective immediately.     As Vice President and General Manager, Mr. Sirois will be responsible for building Nightingale’s presence in the Quebec (EMR) market, establishing relationships and partnerships with leading edge clinics, healthcare providers and other healthcare technology vendors and for bringing Nightingale’s expertise to the province.  Mr. Sirois’ appointment follows Nightingale’s December 2011 acquisition of assets related to Medrium Inc’s Practice Management software business, which included a development team in Quebec City. The Quebec City-based development team will play a significant role in leading Nightingale’s technology innovation and development plans in Quebec and across North America.   In addition to his leadership position in Quebec, Mr. Sirois will also take on the role of Vice President of Consumer eHealth for North America. He will oversee the Company’s further penetration of the growing consumer eHealth market, through the expansion of Nightingale’s Patient Access offering and the introduction of other patient-centric products and services.    A respected industry veteran, Mr. Sirois has more than 15 years of experience in the Healthcare IT market, helping organizations launch innovative technologies.  Most recently, he served as Vice President of Consumer Health at a major Canadian telecommunication company, where he launched consumer eHealth offerings and spearheaded other healthcare IT initiatives.  Before his role in the telecommunication industry, Mr. Sirois was Vice President of Business Development and Chief Operating Officer at Telesystem and Plexo, where he managed a network of clinics, medical labs, radiology centres and corporate medical services.  Mr. Sirois was also the co-founder of Resonant Medical, a leading provider of image-guided radiotherapy equipment that was sold to Elekta Medical in 2009.  Mr. Sirois has an undergraduate degree from McGill University and an MBA from Harvard Business School.   “We believe Luc’s leadership and industry experience will serve as valuable assets as we continue to strengthen our foothold in Quebec and work to further penetrate the consumer eHealth market,” said Mr. John Bodolai, Executive Vice President of Nightingale. “With plans to soon launch our bilingual EMR, Quebec is an important target market for us.  We are excited about furthering our investment in the province and adding breadth and depth to our Quebec-based team.”    “Nightingale is committed to helping physicians enhance patient healthcare,” said Mr. Sirois. “I am a firm believer that the type of innovation we are bringing to market will shape, in many ways, the way medical practices will function in the future.  With access to more than 6,000,000 patients through its existing customer base of healthcare practitioners, Nightingale is already in an enviable position to make a real difference in the quality of patient care and the physician-patient relationship; not only nationally, but in North-America.”    The addition of Mr. Sirois to the Nightingale management team is part of the Company’s strategy to leverage its investments in a bilingual platform across the country. Nightingale was recently awarded a multimillion dollar contract by the Association of Ontario Health Centers to deploy a bilingual platform to 3,500 healthcare providers over a two-year period.   About Nightingale Informatix Corporation (www.nightingalemd.com)  Nightingale is one of the fastest growing health care service and software companies in North America and is recognized as an industry leader in Web-based clinician and community based electronic medical records (EMR) and patient portals the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management, transcription and revenue cycle management, Nightingale’s comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base. Nightingale – Healthcare connected.    Media Inquiries Sharmeen Arafat Marketing Manager 905.307.3617 sarafat@nightingalemd.com   Investor Inquiries Kristen Dickson, M.Sc. Equicom, a TMX Group Company Tel: 416.815.0700 ext. 273 kdickson@equicomgroup.com   Forward looking statement   Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.  Tue, 17 Jan 2012 12:00:00 AM http://www.nightingalemd.ca/news-events/press-releases/?i=3346  Markham, ON, January 13, 2012 – Nightingale Informatix Corporation www.nightingalemd.com (TSX-V:  NGH) “Nightingale” or “Company”, an application service provider (ASP) of  electronic medical record (EMR) software and related services, today announced the redemption of 133 of its existing 12% convertible unsecured subordinated debentures at a price of $133,000 and the issuance, on a non-brokered private placement basis, of 125 12% convertible unsecured subordinated debentures (the “Debentures”) under the same terms, as a replacement, for total gross proceeds of $125,000.   The 125 Debentures bear 12% interest calculated and payable in cash monthly, and are scheduled to mature on January 15, 2016. The Company has the right to redeem the Debentures, in whole or in part, at a price equal to their principal amount plus accrued and unpaid interest. The Debentures are convertible at the holder's option into fully-paid common shares at any time prior to maturity or redemption at a conversion price of $0.35 per share. About Nightingale Informatix Corporation (www.nightingalemd.com) Nightingale is one of the fastest growing health care service and software companies in North America and is recognized as an industry leader in Web-based clinician and community based electronic medical records (EMR) serving the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management, transcription and revenue cycle management, Nightingale’s comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base. Nightingale – Health care connected. www.nightingalemd.com   Investor Inquiries Michael Ford CFO, Nightingale Informatix Corporation Tel: 905.307.7870 mford@nightingalemd.com   Kristen Dickson, M.Sc. TMX Equicom Tel: 416.815.0700 ext. 273 kdickson@equicomgroup.com      Forward Looking Statement Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Fri, 13 Jan 2012 12:00:00 AM